Hong Kong-listed innovative drug concept stocks surged in the afternoon, with WuXi Biologics (02269.HK) and WuXi AppTec (02359.HK) rising over 9%, BeiGene (06160.HK) rising over 7%, and CSPC Pharmaceutical Group (01093.HK) and Akeso Biopharma (09926.HK) following suit.